Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 312
Selected: 0
NCT IDTitle
NCT02729194Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
NCT02463994A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
NCT00156260Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
NCT04203160Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
NCT03352427Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
NCT00176748Treatment for Patients With Metastatic Thyroid Cancer
NCT00148122A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer
NCT05583422Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT02085525A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation
NCT00141739Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
NCT00115739Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
NCT00156286Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC
NCT02679586Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy
NCT03781986APG-115 in Salivary Gland Cancer Trial
NCT00637390A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
NCT00143884Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
NCT05704790Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patients
NCT00399321A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
NCT00810602Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
NCT05945121Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT05866302Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT02409121A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
NCT03617484Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
NCT06094621Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery
NCT05552664The Genetic Information and Family Testing (GIFT) Study
NCT04076579Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
NCT02805179A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
NCT06914479Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
NCT05780879A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia
NCT02436408VISmodegib for ORbital and Periocular Basal Cell Carcinoma
NCT03763838Acupressure for Fatigue in Ovarian Cancer Survivors
NCT06073223Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
NCT00242190Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
NCT06616155Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT06046014Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
NCT06617455Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial
NCT00134355Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
NCT04497038Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
NCT04396808Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NCT00146055Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
NCT06356155Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
NCT01896050Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
NCT01986738A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
NCT02946008Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer
NCT03286114Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
NCT00150995Tetrathiomolybdate in Hormone Refractory Prostate Cancer
NCT00027495Curcumin for the Prevention of Colon Cancer
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT02145403Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
NCT02031250Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer